Using survey responses from the vision loss community-from But several aspects of our vision researchĪnd health care system are in need of development and support, includingĬlinical trials, new medicines for rare diseases, and overall research andĭevelopment. Loss in various ways-sometimes beneficially, if a treatment is widely availableĪnd integrated into public plans. These systems affect Canadians with vision This framework is designed to ensure the safety and cost-effectiveness of drugsĪnd technologies, but the fact remains that Canada adopts new treatments later Recommendations are passed to provinces and territories for public funding.
Our regulatory systems are uniqueĪs well, with four separate national agencies reviewing new treatments before Led to inequitable care in certain contexts. That said, many policy analysts and commentators are quick to point out that our system has aged poorly, particularly when treating chronic illnesses, maintaining electronic records, providing access to pharmaceutical care, adopting gene therapies and other personalized medicines, and in other areas.Īt the same time, due to health care beingĭelivered in Canada by each of its provinces and territories-which amounts,Įssentially, to thirteen separate micro-systems-issues and inconsistencies have Pioneered in the 1960s by Tommy Douglas in Saskatchewan, Canada’s public health care system has long been a source of national pride. 2020 Vision Summit – Equity and Access to Vision Care
0 kommentar(er)
